Livzon Pharmaceutical Group Inc. (SHE:000513)
30.85
-0.43 (-1.37%)
Nov 20, 2026, 3:04 PM CST
| Market Cap | 24.35B -18.2% |
| Revenue (ttm) | 10.22B -13.7% |
| Net Income | 1.56B -27.3% |
| EPS | 1.75 -26.5% |
| Shares Out | 887.91M |
| PE Ratio | 17.59 |
| Forward PE | 15.85 |
| Dividend | 1.43 (4.64%) |
| Ex-Dividend Date | Oct 14, 2026 |
| Volume | 8,777,113 |
| Open | 31.52 |
| Previous Close | 31.28 |
| Day's Range | 30.74 - 31.52 |
| 52-Week Range | 25.70 - 37.42 |
| Beta | 0.16 |
| Analysts | Buy |
| Price Target | 30.09 (-2.46%) |
| Earnings Date | Oct 23, 2026 |